Issues relating to access and coverage of immunizations, including vaccine safety net for uninsured adults, and recovery of missed routine adult vaccines.
CDC Immunization Program.
Hepatitis B vaccination, quality measures, Immunization data, ACIP, timely vaccination, vaccine cost sharing, maternal vaccination, lyme disease.
Implementation of Section 11401 and 11405 of the Inflation Reduction Act.
Duration: July 29, 2015
to
present
General Issues: Health Issues , Budget/Appropriations , Medicare/Medicaid
Spending: about $1,700,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2015: House of Representatives, U.S. Senate, White House Office, Centers For Medicare and Medicaid Services (CMS), Health & Human Services - Dept of (HHS), Office of Management & Budget (OMB), Centers For Disease Control & Prevention (CDC)
Related Foreign Entities:
Sanofi SA (with respect to Line 13 affiliated organization Sanofi Pasteur Inc.) (Paris, FRA); contribution to lobbying: $0; ownership 100%; AstraZeneca plc (with respect to Line 13 affiliated organization MedImmune) (London W2 6BD, GBR); contribution to lobbying: $0; ownership 100%
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Lisa Foster Senior Policy Advisor, Sen. Jack Reed
Abby Bownas Staff Assistant, Sen. Bob Kerrey; Legislative Correspondent, Sen. Harry Reid; Executive Aide, Scheduler, Office Manager, Legislative Assistant, Rep. John Tierney
Andrea LaRue Rules Committee Counsel, Senator Christopher Dodd; Counsel, Senator Thomas A. Daschle; Legislative Assistant & District Director, Congressman Michael A. Andrews
Irene Bueno Legis. Asst. and Dist. Dir., Cong. Andrews; Legis. Asst., Cong. Roybal; Legis. Asst., Sen. Cranston; Spec. Asst. to Asst. Secy for Legislation, HHS; Dep. Asst. Secy for Legislation, HHS; Spec. Asst. to the President, White House
Jane Loewenson Health Fellow, Sen. George Mitchell, Prof. Staff Member, Subcomm. on Children and Families of the Sen. Labor and Human Resources Committee; Sen. Chris Dodd, Sr Health Policy Advisor; Sen. Thomas Daschle, Sr Health Policy Advisor
Joshua Hurvitz Legislative Director, Rep. Anthony Weiner; Sr. LA & LA, Rep. Anthony Weiner.
Katie Pischke n/a
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on April 22.
Original Filing: 301572366.xml
Lobbying Issues
Issues relating to access and coverage of immunizations, including vaccine safety net for uninsured adults, and recovery of missed routine adult vaccines.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CDC Immunization Program.
Hepatitis B vaccination, quality measures, Immunization data, ACIP, timely vaccination, vaccine cost sharing, maternal vaccination, lyme disease.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Implementation of Section 11401 and 11405 of the Inflation Reduction Act.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2023
In Q4, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on Jan. 21.
Original Filing: 301534797.xml
Lobbying Issues
Issues relating to access and coverage of immunizations, including vaccine safety net for uninsured adults, and recovery of missed routine adult vaccines.
H.R.4420 - Preparedness and Response Reauthorization Act.
H.R.4421 - Preparing for All Hazards and Pathogens Reauthorization Act.
S.2333 - Pandemic and All-Hazards Preparedness and Response Act.
Vaccine issues related to the end of the Public Health Emergency (PHE).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CDC Immunization Program.
Uninsured adult access to immunization, data, ACIP, routine, maternal and hepatitis B vaccination, lyme disease, Medicare reimbursement, and OIDP/NVPO.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Implementation of Section 11401 and 11405 of the Inflation Reduction Act.
Immunization Quality Measures.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2023
In Q3, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on Oct. 20, 2023.
Original Filing: 301511789.xml
Lobbying Issues
Issues relating to access and coverage of immunizations, including vaccine safety net for uninsured adults, and recovery of missed routine adult vaccines.
Reauthorization of the Public Health and All Hazards Preparedness Act (PAHPA).
H.R.4420 - Preparedness and Response Reauthorization Act.
H.R.4421 - Preparing for All Hazards and Pathogens Reauthorization Act.
S.2333 - Pandemic and All-Hazards Preparedness and Response Act.
Vaccine issues related to the end of the Public Health Emergency (PHE).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CDC Immunization Program.
Uninsured adult access to immunization, data, ACIP, routine, maternal and hepatitis B vaccination, lyme disease, Medicare reimbursement, and OIDP/NVPO.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Implementation of Section 11401 and 11405 of the Inflation Reduction Act.
Immunization Quality Measures.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2023
In Q2, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on July 20, 2023.
Original Filing: 301490967.xml
Lobbying Issues
Access to immunizations, including vaccine safety net and recovery of missed routine adult vaccines.
Reauthorization of the Public Health and All Hazards Preparedness Act (PAHPA).
Vaccine issues related to the end of the Public Health Emergency (PHE).
Vaccine program for uninsured adults.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CDC Immunization Program.
Uninsured adult access to immunization, data, ACIP, routine, maternal and hepatitis B vaccination, lyme disease, Medicare reimbursement, and OIDP/NVPO.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Implementation of Section 11401 and 11405 of the Inflation Reduction Act.
Immunization Quality Measures.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2023
In Q1, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on April 20, 2023.
Original Filing: 301459788.xml
Lobbying Issues
Access to immunizations, including vaccine safety net and recovery of missed routine adult vaccines.
Reauthorization of the Public Health and All Hazards Preparedness Act (PAHPA).
Vaccine issues related to the end of the Public Health Emergency (PHE).
Vaccine program for uninsured adults.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CDC Immunization Program.
Uninsured adult access to immunization, data, ACIP, routine, maternal and hepatitis B vaccination, lyme disease, Medicare reimbursement, and OIDP/NVPO.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Implementation of Section 11401 and 11405 of the Inflation Reduction Act.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2022
In Q4, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on Jan. 20, 2023.
Original Filing: 301438523.xml
Lobbying Issues
Access to immunizations, including vaccine safety net and recovery of missed routine adult vaccines.
S.3799 - Prepare for and Respond to Existing Viruses, Emerging New Threats (PREVENT) Pandemics Act.
Vaccine issues related to the end of the Public Health Emergency (PHE).
P.L.117-328 - Consolidated Appropriations Act, 2023.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CDC Immunization Program.
Access to immunizations, IIS, quality measures, Medicare Part D cost sharing for vaccines, and hepatitis B immunization and vaccine administration in the House and Senate FY 2023 LHHS Appropriations bill.
Funding for COVID and Monkeypox activities in the supplemental.
P.L.117-328 - Consolidated Appropriations Act, 2023.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Implementation of Section 11401 and 11405 of the Inflation Reduction Act.
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2022
In Q3, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on Oct. 20, 2022.
Original Filing: 301415329.xml
Lobbying Issues
Recovery of missed routine adult vaccines.
S.3799 - Prepare for and Respond to Existing Viruses, Emerging New Threats (PREVENT) Pandemics Act.
Vaccine issues related to the end of the Public Health Emergency (PHE).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CDC Immunization Program.
Access to immunizations, IIS, quality measures, Medicare Part D cost sharing for vaccines, and hepatitis B immunization and vaccine administration in the House and Senate FY 2023 LHHS Appropriations bill.
Funding for COVID and Monkeypox activities in the supplemental.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2022
In Q2, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on July 20, 2022.
Original Filing: 301394597.xml
Lobbying Issues
Ensuring people are current on missed vaccines.
H.R.951/S.345 - Maternal Vaccination Act, and and provisions from the act included in H.R.959/S.345, Black Maternal Health Momnibus Act of 2021.
Implementation of vaccine infrastructure and confidence activities in the American Rescue Plan Act of 2021 (P.L. 117-2).
S.3799 - Prepare for and Respond to Existing Viruses, Emerging New Threats (PREVENT) Pandemics Act.
H.R.6000 - Cures 2.0 Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CDC Immunization Program.
Access to immunizations, IIS, quality measures, Medicare Part D cost sharing for vaccines, and hepatitis B immunization and vaccine administration in the House and Senate FY 2022 LHHS Appropriations bill.
Funding for vaccine infrastructure and confidence activities in the American Rescue Plan Act of 2021 (P.L. 117-2).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Part D cost sharing.
Eliminating costs sharing in Medicare and Medicaid through Budget reconciliation.
H.R.1978/S.912 - Protecting Seniors Through Immunization Act of 2021.
H.R.2170/S.581 - Helping Adults Protect Immunity (HAPI) Act.
Agencies Lobbied
U.S. Senate
1st Quarter, 2022
In Q1, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on April 20, 2022.
Original Filing: 301368189.xml
Lobbying Issues
Access to immunizations.
H.R.951/S.345 - Maternal Vaccination Act, and and provisions from the act included in H.R.959/S.345, Black Maternal Health Momnibus Act of 2021.
H.R.550 - Immunization Infrastructure Modernization Act of 2021.
Implementation of vaccine infrastructure and confidence activities in the American Rescue Plan Act of 2021 (P.L. 117-2).
S.3799 - Prepare for and Respond to Existing Viruses, Emerging New Threats (PREVENT) Pandemics Act.
H.R.6000 - Cures 2.0 Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CDC Immunization Program.
Access to immunizations, IIS, quality measures, Medicare Part D cost sharing for vaccines, and hepatitis B immunization and vaccine administration in the House and Senate FY 2022 LHHS Appropriations bill.
Funding for vaccine infrastructure and confidence activities in the American Rescue Plan Act of 2021 (P.L. 117-2).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Part D cost sharing.
Quality measures for vaccines.
H.R.1978/S.912 - Protecting Seniors Through Immunization Act of 2021.
H.R.2170/S.581 - Helping Adults Protect Immunity (HAPI) Act.
Agencies Lobbied
U.S. Senate
4th Quarter, 2021
In Q4, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on Jan. 20, 2022.
Original Filing: 301335872.xml
Lobbying Issues
Access to immunizations;
Maternal immunizations;
Immunization infrastructure;
Health information technology/immunization information systems (IIS);
Vaccine equity;
Vaccine education/confidence;
Quality measures;
Community Immunity During COVID-19 Act of 2021 (H.R. 736/S. 167);
Immunization Infrastructure Modernization Act (H.R. 550);
Maternal Vaccinations Act (H.R. 951/S. 345), and provisions from the act included in the Black Maternal Health Momnibus (H.R. 959/S. 345);
Implementation of vaccine infrastructure and confidence activities in the American Rescue Plan Act of 2021 (P.L. 117-2);
The PREVENT HPV Cancers Act of 2021 (H.R. 1550).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CDC Immunization Program;
Support for immunization infrastructure;
Access to immunizations, immunization information systems, quality measures, Medicare Part D cost sharing for vaccines, and hepatitis B immunization and vaccine administration in the House and Senate FY 2022 LHHS Appropriations bill;
Funding for vaccine infrastructure and confidence activities in the American Rescue Plan Act of 2021 (P.L. 117-2);
Eliminating financial barriers to vaccines as part of the Build Back Better Act (H.R. 5376).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Part D cost sharing;
Quality measures for vaccines;
Medicare reimbursement for vaccine education, counseling, and administration;
Protecting Seniors Through Immunization Act (H.R. 1978/S. 912);
Maternal Immunization Coverage Act (S. 1117);
Maternal Immunization Enhancement Act (S. 1114);
Helping Adults Protect Immunity (HAPI) Act (H.R. 2170/S. 581);
Eliminating financial barriers to vaccines as part of the Build Back Better Act (H.R. 5376).
Agencies Lobbied
U.S. Senate
3rd Quarter, 2021
In Q3, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on Oct. 20, 2021.
Original Filing: 301312237.xml
Lobbying Issues
Access to immunizations;
Maternal immunizations;
Immunization infrastructure;
Health information technology/IIS;
Vaccine equity;
Vaccine education/confidence;
Quality measures;
H.R. 736/S. 167, Community Immunity During COVID-19 Act of 2021;
H.R. 550, Immunization Infrastructure Modernization Act;
H.R. 951/S. 345, Maternal Vaccinations Act, and provisions from the act included in H.R. 959/S. 345, Black Maternal Health Momnibus;
Implementation of vaccine infrastructure and confidence activities in the American Rescue Plan Act of 2021 (P.L. 117-2);
H.R. 1550, the PREVENT HPV Cancers Act of 2021.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CDC Immunization Program;
Support for immunization infrastructure;
Access to immunizations, immunization information systems (IIS), quality measures, Medicare Part D cost sharing for vaccines, and hepatitis B immunization and vaccine administration in the House and Senate FY 22 LHHS Appropriations bill;
Funding for vaccine infrastructure and confidence activities in the American Rescue Plan Act of 2021 (P.L. 117-2);
Eliminating financial barriers to vaccines as part of the Build Back Better Act (H.R. 5376).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Part D cost sharing;
Quality measures for vaccines;
Medicare reimbursement for vaccine education, counseling, and administration;
S. 912/H.R. 1978, Protecting Seniors Through Immunization Act;
S. 1117, Maternal Immunization Coverage Act;
S. 1114, Maternal Immunization Enhancement Act;
S. 581/H.R. 2170, Helping Adults Protect Immunity (HAPI) Act.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2021
In Q2, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on July 20, 2021.
Original Filing: 301284264.xml
Lobbying Issues
Access to immunizations;
Maternal immunizations;
Immunization infrastructure;
Health information technology/IIS;
Vaccine equity;
Vaccine education/confidence;
Quality measures;
H.R. 736/S. 167, Community Immunity During COVID-19 Act of 2021;
H.R. 550, Immunization Infrastructure Modernization Act;
H.R. 951/S. 345, Maternal Vaccinations Act, and provisions from the act included in H.R. 959/S. 345 Black Maternal Health Momnibus;
Implementation of vaccine infrastructure and confidence activities in the American Rescue Plan Act of 2021 (P.L. 117-2);
H.R. 1550, the PREVENT HPV Cancers Act of 2021.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CDC Immunization Program;
Support for immunization infrastructure;
Access to immunizations, Immunization information systems (IIS), Quality measures, Medicare Part D cost sharing for vaccines, and hepatitis B immunization and vaccine administration in the House and Senate FY 22 LHHS Appropriations bill;
Funding for vaccine infrastructure and confidence activities in the American Rescue Plan Act of 2021 (P.L. 117-2).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Part D cost sharing and quality measures for vaccines;
Medicare reimbursement for vaccine education, counseling and administration;
S. 912/H.R. 1978, Protecting Seniors Through Immunization Act;
S. 1117, Maternal Immunization Coverage Act;
S. 1114, Maternal Immunization Enhancement Act;
S. 581/H.R. 2170 Helping Adults Protect Immunity (HAPI) Act.
Agencies Lobbied
U.S. Senate
1st Quarter, 2021
In Q1, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on April 20, 2021.
Original Filing: 301263638.xml
Lobbying Issues
Access to immunizations;
Maternal immunizations;
Immunization infrastructure;
Health information technology/IIS;
Vaccine equity;
Vaccine education/confidence;
Quality measures;
H.R. 2862, VACCINES Act;
H.R. 736/S. 167 Community Immunity During COVID-19 Act of 2021;
H.R. 550 Immunization Infrastructure Modernization Act;
Vaccine provisions in H.R. 959/S. 345 Black Maternal Health Momnibus;
Funding for vaccine infrastructure and confidence activities in the American Rescue Plan Act of 2021 (P.L. 117-2).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CDC Immunization Program;
Support for immunization infrastructure;
Access to immunizations, Immunization information systems (IIS), Quality measures, Medicare Part D cost sharing for vaccines, and hepatitis B immunization and vaccine administration in the House and Senate FY 22 LHHS Appropriations bill;
Funding for vaccine infrastructure and confidence activities in the American Rescue Plan Act of 2021 (P.L. 117-2).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Part D cost sharing and quality measures for vaccines;
Medicare reimbursement for vaccine education, counseling and administration;
S. 912/H.R. 1978, Protecting Seniors Through Immunization Act;
Reintroduction of the Maternal Immunization Coverage Act to the 117th Congress;
Reintroduction of the Maternal Immunization Enhancement Act to the 117th Congress;
S. 581/H.R. 2170 Helping Adults Protect Immunity (HAPI) Act.
Agencies Lobbied
U.S. Senate
4th Quarter, 2020
In Q4, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on Jan. 19, 2021.
Original Filing: 301237234.xml
Lobbying Issues
Access to immunizations;
Maternal immunizations;
Immunization infrastructure;
Health information technology/IIS;
Quality measures;
H.R. 2862, VACCINES Act;
H.R.8061/S.4737 Community Immunity During COVID-19 Act of 2020;
S.4269 Mothers and Newborns Success Act;
S.4469 - 116th Congress (2019-2020) COVID-19 Treatment Coverage Act;
Funding for vaccine infrastructure for Consolidated Appropriations Act 2021 (P.L. 116-260).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CDC Immunization Program;
Support for immunization infrastructure;
Access to immunizations, Immunization information systems(IIS), Quality measures, Medicare Part D cost sharing for vaccines, and hepatitis B immunization and vaccine administration in the House and Senate FY 21 LHHS Appropriations bill and H.R. 7614, the House FY21 LHHS Appropriations bills;
Funding for vaccine infrastructure for Consolidated Appropriations Act 2021 (Pub.L. 116-2600).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Part D cost sharing and quality measures for vaccines;
S. 1872/H.R. 5076, Protecting Seniors Through Immunization Act;
Medicare reimbursement for vaccine education, counseling and administration;
S.4705 Maternal Immunization Coverage Act;
S. 4690 Maternal Immunization Enhancement Act;
H.R.8623 /S. 4825 Ensuring Access to COVID-19 Vaccines for Seniors Act;
S.4864 /H.R.8725 Helping Adults Protect Immunity (HAPI) Act S.4469 - 116th Congress.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2020
In Q3, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on Oct. 20, 2020.
Original Filing: 301222941.xml
Lobbying Issues
Access to immunizations;
Maternal immunizations;
Immunization infrastructure;
Health information technology/IIS;
Quality measures;
H.R. 2862, VACCINES Act;
HR 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or the HEROES Act;
HR 925, Health and Economic Recovery Omnibus Emergency Solutions Act 2.0 or the HEROES Act 2.0;
HR8061/S.4737 Community Immunity During COVID-19 Act of 2020;
S.4269 Mothers and Newborns Success Act;
S.4469 - 116th Congress (2019-2020) COVID-19 Treatment Coverage Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CDC Immunization Program;
Support for immunization infrastructure;
Access to immunizations, Health information technology/IIS, Quality measures, and Medicare Part D cost sharing for vaccines, and hepatitis B immunization and vaccine administration in the House and Senate FY 21 LHHS Appropriations bill and H.R. 7614, the House FY21 LHHS Appropriations bills.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Part D cost sharing and quality measures for vaccines;
S. 1872/H.R. 5076, Protecting Seniors Through Immunization Act;
Medicare reimbursement for vaccine education, counseling and administration;
S. 4705 A bill to amend title XIX requiring coverage under Medicaid of vaccines for pregnant women;
S. 4690 A bill to increase vaccination rates among pregnant women enrolled in Medicaid or CHIP, and for other purposes.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2020
In Q2, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on July 20, 2020.
Original Filing: 301197100.xml
Lobbying Issues
Access to immunizations;
Maternal immunizations;
Health information technology/IIS;
Quality measures;
HHS Healthy People 2030 Process;
H.R. 2862, VACCINES Act;
S. 1872/H.R. 5076, Protecting Seniors Through Immunization Act;
CARES Act - Public Law No: 116-136;
Families First Coronavirus Response Act - Public Law No: 116-127;
Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020 - Public Law No: 116-123;
HR 6800, Health and Economic Recovery Omnibus Emergency Solutions Act or the HEROES Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CDC Immunization Program;
Access to immunizations, Health information technology/IIS, Quality measures, and Medicare Part D cost sharing for vaccines, and hepatitis B immunization and vaccine administration in the House and Senate FY 21 LHHS Appropriations bill and H.R. 7614, the House FY21 LHHS Appropriations bills.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Part D cost sharing and quality measures for vaccines;
S. 1872/H.R. 5076, Protecting Seniors Through Immunization Act;
Medicare reimbursement for vaccine education, counseling and administration.
Agencies Lobbied
U.S. Senate
1st Quarter, 2020
In Q1, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on April 20, 2020.
Original Filing: 301177407.xml
Lobbying Issues
Access to immunizations;
Health information technology/IIS;
Quality measures;
HHS Healthy People 2030 Process;
H.R. 2862, VACCINES Act;
S. 1872/H.R. 5076, Protecting Seniors Through Immunization Act;
CARES Act - Public Law No: 116-136;
Families First Coronavirus Response Act - Public Law No: 116-127.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CDC Immunization Program:
Access to immunizations, Health information technology, Quality measures, and Medicare Part D cost sharing for vaccines, hepatitis B immunization and vaccine administration in the House and Senate FY 21 LHHS Appropriations bills.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Part D cost sharing and quality measures for vaccines;
S. 1872/H.R. 5076, Protecting Seniors Through Immunization Act.
Agencies Lobbied
U.S. Senate
4th Quarter, 2019
In Q4, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on Jan. 21, 2020.
Original Filing: 301126632.xml
Lobbying Issues
Access to immunizations;
Health information technology/IIS;
Quality measures;
HHS Healthy People 2030 Process;
S. 1895, Lower Health Care Costs Act;
H. Res 592, Recognizing the anniversary of the eradication of smallpox and the importance of vaccination in the United States and worldwide;
H.R. 2862, VACCINES Act;
H.R. 4334, Dignity in Aging Act;
S. 1872, Protecting Seniors Through Immunization Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CDC Immunization Program:
Access to immunizations, Health information technology, Quality measures, and Medicare Part D cost sharing for vaccines, and CDC coordination on hepatitis B immunization and vaccine administration in the House and Senate FY 20 LHHS Appropriations bill (H.R. 2740).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Part D cost sharing and quality measures for vaccines;
Protecting Seniors Through Immunization Act, S.1872.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2019
In Q3, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on Oct. 16, 2019.
Original Filing: 301066299.xml
Lobbying Issues
Access to immunizations;
Health information technology/IIS;
Quality measures;
HHS Healthy People 2030 Process;
S. 1895, Lower Health Care Costs Act;
H. Res 592, Recognizing the anniversary of the eradication of smallpox and the importance of vaccination in the United States and worldwide;
H.R. 2862, VACCINES Act;
H.R. 4334, Dignity in Aging Act;
S. 1872, Protecting Seniors Through Immunization Act.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CDC Immunization Program:
Access to immunizations, Health information technology, Quality measures, and Medicare Part D cost sharing for vaccines, and CDC coordination on hepatitis B immunization and vaccine administration in the House and Senate FY 20 LHHS Appropriations bill (H.R. 2740).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Part D cost sharing and quality measures for vaccines;
Protecting Seniors Through Immunization Act, S.1872.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2019
In Q2, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on July 22, 2019.
Original Filing: 301055694.xml
Lobbying Issues
Access to immunizations;
Health information technology/IIS;
Quality measures;
Medicare Part D cost-sharing for immunizations;
HHS Healthy People 2030 Process.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CDC Immunization Program: National Vaccine Program Office; Flu Program;
Access to immunizations, Health information technology, Quality measures, and Medicare Part D cost sharing for vaccines, and CDC coordination on hepatitis B immunization and vaccine administration in the House and Senate FY 20 LHHS Appropriations bill (H.R. 2740).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Part D cost sharing and quality measures for vaccines;
Protecting Seniors Through Immunization Act, S.1872.
Agencies Lobbied
U.S. Senate
1st Quarter, 2019
In Q1, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on April 18, 2019.
Original Filing: 301029932.xml
Lobbying Issues
Access to immunizations;
Health information technology/IIS;
Quality measures;
Medicare Part D cost-sharing for immunizations;
HHS Healthy People 2030 Process.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CDC Immunization Program: National Vaccine Program Office; Flu Program;
Access to immunizations, Health information technology, Quality measures, and Medicare Part D cost sharing for vaccines, and CDC coordination on hepatitis B immunization and vaccine administration in the FY 19/FY 20 LHHS Appropriations bill.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Part D cost sharing and quality measures for vaccines.
Agencies Lobbied
U.S. Senate
4th Quarter, 2018
In Q4, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on Jan. 17, 2019.
Original Filing: 301006465.xml
Lobbying Issues
Access to immunizations;
Health information technology/IIS;
Quality measures;
Medicare Part D cost-sharing for immunizations;
Pandemic and All-Hazards Preparedness and Advancing Innovation Act (S. 2852/H.R. 6378).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CDC Immunization Program: National Vaccine Program Office;
Access to immunizations, Health information technology, Quality measures, and Medicare Part D cost sharing for vaccines, and CDC coordination on hepatitis B immunization and vaccine administration in the FY 19 LHHS Appropriations bill (P.L. 115-245).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Part D cost sharing and quality measures for vaccines.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2018
In Q3, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on Oct. 18, 2018.
Original Filing: 300988779.xml
Lobbying Issues
Access to immunizations;
Health information technology/IIS;
Quality measures;
Medicare Part D cost-sharing for immunizations;
Protecting Seniors Through Immunization Act (S. 3477/H.R. 4297).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CDC Immunization Program: National Vaccine Program Office;
Access to immunizations, Health information technology, Quality measures, and Medicare Part D cost sharing for vaccines and CDC coordination on hepatitis B immunization in the House and Senate FY 19 LHHS Appropriations bill (P.L. 115-245).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Part D cost sharing and quality measures for vaccines.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2018
In Q2, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on July 20, 2018.
Original Filing: 300977855.xml
Lobbying Issues
Access to immunizations;
Health information technology/IIS;
Quality measures;
Medicare Part D cost-sharing for immunizations;
Protecting Seniors Through Immunization Act (S. 3477/H.R. 4297).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CDC Immunization Program: National Vaccine Program Office;
Access to immunizations, Health information technology, Quality measures, and Medicare Part D cost sharing for vaccines within CDC coordination on hepatitis B immunization and rural health clinics reimbursement for vaccines in the FY 19 LHHS Appropriations bill.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Part D cost sharing and quality measures for vaccines.
Agencies Lobbied
U.S. Senate
1st Quarter, 2018
In Q1, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on April 20, 2018.
Original Filing: 300957206.xml
Lobbying Issues
Access to immunizations;
Health information technology/IIS;
Quality measures;
Medicare Part D cost-sharing for immunizations;
Protecting Seniors Through Immunization Act (S. 3477/H.R. 4297).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CDC Immunization Program: National Vaccine Program Office;
Access to immunizations, Health information technology, Quality measures, and Medicare Part D cost sharing for vaccines in the FY 18 LHHS Appropriations bill;
FY 18 appropriations for immunization funding;
FY 19 appropriations for immunization funding.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Part D cost sharing and quality measures for vaccines.
Agencies Lobbied
U.S. Senate
4th Quarter, 2017
In Q4, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on Jan. 22, 2018.
Original Filing: 300936794.xml
Lobbying Issues
Access to immunizations;
Health information technology/IIS;
Quality measures;
Medicare Part D cost-sharing for immunizations;
Protecting Seniors Through Immunization Act (S. 3477/H.R. 4297).
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
CDC Immunization Program: National Vaccine Program Office;
Access to immunizations, Health information technology, Quality measures, and Medicare Part D cost sharing for vaccines in the FY 18 LHHS Appropriations bill.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Part D cost sharing and quality measures for vaccines.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2017
In Q3, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on Oct. 20, 2017.
Original Filing: 300916528.xml
Lobbying Issues
Access to immunizations;
Health information technology;
Quality measures;
Medicare Part D cost-sharing for vaccines;
H.R. 1628, American Health Care Act of 2017; Better Care Reconciliation Act; Graham-Cassidy amendment
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Access to immunications, Health information technology, Quality measures, and Medicare Part D cost sharing for vaccines in the FY 18 LHHS Appropriations bill.
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2017
In Q2, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on July 20, 2017.
Original Filing: 300895735.xml
Lobbying Issues
Access to immunizations;
Health information technology;
Quality measures;
Medicare Part D cost-sharing for vaccines;
American Health Care Act of 2017, H.R. 1628;
Better Care Reconciliation Act
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Access to immunications;
Health information technology;
Quality measures;
Medicare Part D cost sharing for vaccines;
FY 17 CR and Omnibus appropriations, H.R. 1301;
FY 18 LHHS Appropriations.
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2017
In Q1, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on April 20, 2017.
Original Filing: 300877674.xml
Lobbying Issues
Access to immunizations;
Health information technology;
Quality measures;
Medicare Part D cost-sharing for vaccines;
American Health Care Act of 2017, H.R. 1628.
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Access to immunications;
Health information technology;
Quality measures;
Medicare Part D cost sharing for vaccines;
FY 17 CR and Omnibus appropriations, H.R. 1301.
Agencies Lobbied
U.S. House of Representatives
4th Quarter, 2016
In Q4, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on Jan. 23, 2017.
Original Filing: 300855854.xml
Lobbying Issues
Access to immunizations;
Health information technology;
Quality measures;
Medicare Part D cost-sharing for vaccines;
S. 3477 Protecting Seniors Through Immunization Act of 2016;
H.R. __ Protecting Seniors Through Immunization Act of 2016
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Access to immunizations;
Health information technology;
Quality measures;
Medicare Part D cost sharing for vaccines
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2016
In Q3, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on Oct. 20, 2016.
Original Filing: 300839293.xml
Lobbying Issues
Access to immunizations;
Health information technology;
Quality measures;
Medicare Part D cost-sharing for vaccines
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Access to immunizations;
Health information technology;
Quality measures;
Medicare Part D cost sharing for vaccines
Agencies Lobbied
U.S. House of Representatives
2nd Quarter, 2016
In Q2, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on July 20, 2016.
Original Filing: 300818601.xml
Lobbying Issues
Access to immunizations;
Health information technology;
Quality measures;
Medicare Part D cost-sharing for vaccines
Agencies Lobbied
U.S. House of Representatives
Lobbying Issues
Access to immunizations;
Health information technology;
Quality measures;
Medicare Part D cost sharing for vaccines
Agencies Lobbied
U.S. House of Representatives
1st Quarter, 2016
In Q1, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $50,000. The report was filed on April 20, 2016.
Original Filing: 300801949.xml
Lobbying Issues
Access to immunizations;
Health information technology;
Quality measures;
Medicare Part D cost sharing for vaccines
Agencies Lobbied
U.S. House of Representatives
Type of Issue
Health Issues/Appropriations
4th Quarter, 2015
In Q4, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $30,000. The report was filed on Jan. 20, 2016.
Original Filing: 300783103.xml
Lobbying Issues
Access to immunizations;
Health information technology;
Quality measures
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2015
In Q3, NVG, LLC lobbied for Adult Vaccine Access Coalition , earning $20,000. The report was filed on Dec. 17, 2015.
Original Filing: 300768463.xml
Lobbying Issues
Quality, Health Information Technology and access to immunizations
Agencies Lobbied
U.S. House of Representatives
3rd Quarter, 2015
NVG, LLC filed a lobbying registration on Dec. 1, 2015 to represent Adult Vaccine Access Coalition, effective July 29, 2015.
Original Filing: 300768114.xml
Issue(s) they said they’d lobby about: Issues related to access to, and utilization of, adult vaccinations .
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...